Cinevista Board Meeting Outcome

Cinevista Q2 FY27 Results: Net Profit ₹0.6 Cr, Down 25.0% YoY

Cinevista Ltd reported revenue from operations of ₹5.1 Cr (+34.2% YoY) and net profit of ₹0.6 Cr (-25.0% YoY) for Q2 FY27.

Key figure

Net profit ₹0.6 Cr · -25.0% YoY

Cinevista Board Meeting Date

Cinevista Ltd will hold a Board Meeting on 27 October 2026. It proposes to approve un-audited results for the quarter and half-year ended 30 September 2026.

Cinevista Other Announcement

Cinevista Limited submitted its Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, as received from its RTA, KFin Technologies Limited.

Cinevista Board Meeting Date

Cinevista Ltd intimated a Board Meeting for 22 September 2026 to consider write-offs and ECL provisions. It also proposes striking off three inactive subsidiaries.

Cinevista Q1 FY27 Results: Net Profit ₹1 Cr, Up 0.0% YoY

Cinevista Ltd reported revenue from operations of ₹7.5 Cr (+63.0% YoY) and net profit of ₹1 Cr (+0.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1 Cr · +0.0% YoY

Cinevista Board Meeting Date

Cinevista Limited has scheduled a Board Meeting for August 12, 2026, to consider and approve its standalone and consolidated financial results for the quarter ended June 30, 2026.

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.